EMFAT
PBYI icon

Emerald Mutual Fund Advisers Trust’s Puma Biotechnology PBYI Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-209,624
Closed -$9.61M – 230
2018
Q3 		$9.61M Sell
209,624
-105,400
-33% -$5.08M 0.32% 114
2018
Q2 		$18.6M Sell
315,024
-111
-0% -$6.43K 0.68% 48
2018
Q1 		$21.4M Sell
315,135
-5,208
-2% -$390K 0.84% 31
2017
Q4 		$31.7M Buy
320,343
+29,197
+10% +$3.27M 1.26% 14
2017
Q3 		$34.9M Buy
291,146
+43,108
+17% +$4.01M 1.45% 6
2017
Q2 		$21.7M Sell
248,038
-12,779
-5% -$715K 0.95% 31
2017
Q1 		$9.7M Buy
+260,817
New +$9.52M 0.44% 77
2015
Q2 		– Sell
-26,322
Closed -$5.25M – 267
2015
Q1 		$5.25M Sell
26,322
-17,211
-40% -$3.68M 0.43% 88
2014
Q4 		$8.24M Buy
43,533
+19,533
+81% +$4.33M 0.72% 53
2014
Q3 		$5.73M Buy
+24,000
New +$4.93M 0.55% 67

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's PBYI Position: Q4 2018 in Review

Emerald Mutual Fund Advisers Trust sold out of Puma Biotechnology (PBYI) in Q4 2018, closing a stake of 209,624 shares — an estimated $9.61M sold.

Emerald Mutual Fund Advisers Trust first reported a position in PBYI in Q3 2014 and held it in 10 quarters. The position peaked at $34.9M in Q3 2017. 141 funds tracked by Wall St. Rank hold PBYI as of Q4 2018.

  • Emerald Mutual Fund Advisers Trust reported no remaining Puma Biotechnology position as of Q4 2018 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 209,624 Puma Biotechnology shares in Q4 2018, an estimated $9.61M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Puma Biotechnology in Q3 2014 and held it in 10 quarters.
  • Emerald Mutual Fund Advisers Trust's Puma Biotechnology position peaked at $34.9M in Q3 2017.
  • 141 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2018.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2018, filed 30 Jan 2019.